SEI Investments
ARCT icon

SEI Investments’s Arcturus Therapeutics ARCT Stock Holding History

SEI Investments’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,196
Closed -$344K – 2657
2024
Q1 		$344K Buy
10,196
+1,492
+17% +$52.9K ﹤0.01% 2249
2023
Q4 		$274K Buy
+8,704
New +$207K ﹤0.01% 2337
2021
Q2 		– Sell
-5,226
Closed -$222K – 2542
2021
Q1 		$222K Hold
5,226
– – ﹤0.01% 2355
2020
Q4 		$222K Buy
+5,226
New +$354K ﹤0.01% 2329

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

SEI Investments's ARCT Position: Q2 2024 in Review

SEI Investments sold out of Arcturus Therapeutics (ARCT) in Q2 2024, closing a stake of 10,196 shares — an estimated $344K sold.

SEI Investments first reported a position in ARCT in Q4 2020 and held it in 4 quarters. The position peaked at $344K in Q1 2024. 171 funds tracked by Wall St. Rank hold ARCT as of Q2 2024.

  • SEI Investments reported no remaining Arcturus Therapeutics position as of Q2 2024 after selling out during the quarter.
  • SEI Investments sold 10,196 Arcturus Therapeutics shares in Q2 2024, an estimated $344K.
  • SEI Investments first reported a position in Arcturus Therapeutics in Q4 2020 and held it in 4 quarters.
  • SEI Investments's Arcturus Therapeutics position peaked at $344K in Q1 2024.
  • 171 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2024.

Based on SEI Investments's 13F filing for Q2 2024, filed 13 Aug 2024.